SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-054004
Filing Date
2024-04-29
Accepted
2024-04-29 16:05:37
Documents
10
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242800-1_def14.htm DEF 14A 712572
2 GRAPHIC bc_netloss-4c.jpg GRAPHIC 62884
3 GRAPHIC bc_paidtsr-4c.jpg GRAPHIC 63371
4 GRAPHIC ic_internet-bw.jpg GRAPHIC 3788
5 GRAPHIC ic_mail-bw.jpg GRAPHIC 2519
6 GRAPHIC ic_tele-bw.jpg GRAPHIC 2553
7 GRAPHIC lg_sellaslifesciences-4clr.jpg GRAPHIC 12973
8 GRAPHIC px_24sellasproxy1pg1-bw.jpg GRAPHIC 231194
9 GRAPHIC px_24sellasproxy1pg2-bw.jpg GRAPHIC 193648
10 GRAPHIC sg_angelosmstergiou-bw.jpg GRAPHIC 7337
  Complete submission text file 0001104659-24-054004.txt   1448963
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 24890604
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)